No Prescription |
 |
 | ||
|
Pioglar GF Duetact |
|
| ||
No Prescription » Prescription Drugs 13 » Pioglar GF Duetact This medication is a combination of 2 drugs pioglitazone and glimepiride. It is used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes (non-insulin-dependent diabetes). Effectively controlling high blood sugar helps prevent heart disease strokes kidney disease blindness circulation problems and sexual function problems (impotence).Pioglitazone belongs to a class of drugs known as thiazolidinediones or "glitazones." It works by helping to restore your body's proper response to insulin thereby lowering your blood sugar.Glimepiride belongs to a class of drugs known as sulfonylureas. It works by causing the release of your body's natural insulin.How to use Pioglitazone/Glimepride OralRead the Patient Information Leaflet provided by your pharmacist before you start taking this medication and each time you get a refill. If you have any questions consult your doctor or pharmacist.Take this medication by mouth usually once daily with the first main meal of the day or as directed by your doctor.The dosage is based on your medical condition and response to treatment. Do not take more than 45 milligrams of pioglitazone a day.Use this medication regularly in order to get the most benefit from it. Remember to take it at the same time each day. Monitor your blood sugar levels on a regular basis and share the results with your doctor.It may take up to 2 to 3 months before you get the full benefit of this drug.When switching from individual diabetes drugs to this combination product your doctor may ask you to check your blood sugar more often to make sure you do not have a sudden attack of low blood sugar (hypoglycemic reaction) when starting this product. (See also Side Effects section.) Follow your doctor's directions carefully. Buy Pioglar GF Duetact and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About Pioglar GF Duetact: Product Type: Prescription Drugs 13 Pioglar GF ( Duetact Generic Pioglitazone/Glimepiride ) Pioglar GF (Duetact Generic Pioglitazone/Glimepiride) Duetact Generic Pioglitazone/Glimepiride 30/2mg Duetact Generic Pioglitazone/Glimepiride Pioglar GF
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
